{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:14:32Z","timestamp":1790252072988,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,10]]},"DOI":"10.1097\/qad.0b013e32833b7830","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T06:52:13Z","timestamp":1276152733000},"page":"2245-2252","source":"Crossref","is-referenced-by-count":21,"title":["Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study"],"prefix":"10.1097","volume":"24","author":[{"given":"Sheena G","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle Boffi El","family":"Amari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas J","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Magouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Biggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rickenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210130","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R2-13-20210130","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study","volume":"282","author":"Ledergerber","year":"1999","journal-title":"JAMA"},{"key":"R3-13-20210130","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.bjc.6604520","article-title":"Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy","volume":"99","author":"Franceschi","year":"2008","journal-title":"Br J Cancer"},{"key":"R4-13-20210130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R5-13-20210130","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/94.16.1204","article-title":"Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998","volume":"94","author":"Eltom","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R6-13-20210130","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0190-9622(98)70124-0","article-title":"Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study","volume":"38","author":"Krischer","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"R7-13-20210130","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/QAD.0b013e3283300a91","article-title":"Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma","volume":"23","author":"Bihl","year":"2009","journal-title":"AIDS"},{"key":"R8-13-20210130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002030-200402200-00015","article-title":"Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viremia","volume":"18","author":"Bourboulia","year":"2004","journal-title":"AIDS"},{"key":"R9-13-20210130","first-page":"779","article-title":"Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy","volume":"27","author":"Cattelan","year":"2005","journal-title":"Int J Oncol"},{"key":"R10-13-20210130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00126334-200212010-00003","article-title":"Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma\u2013associated herpesvirus infection in patients with and without Kaposi sarcoma","volume":"31","author":"Gill","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-13-20210130","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1128\/JCM.39.12.4269-4273.2001","article-title":"Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma","volume":"39","author":"Tedeschi","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R12-13-20210130","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1128\/JVI.76.6.2634-2640.2002","article-title":"Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy","volume":"76","author":"Wilkinson","year":"2002","journal-title":"J Virol"},{"key":"R13-13-20210130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jmv.1031","article-title":"Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS","volume":"64","author":"Quinlivan","year":"2001","journal-title":"J Med Virol"},{"key":"R14-13-20210130","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ijc.22281","article-title":"Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study","volume":"120","author":"Martro","year":"2007","journal-title":"Int J Cancer"},{"key":"R15-13-20210130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ije\/29.1.175","article-title":"Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily","volume":"29","author":"Perna","year":"2000","journal-title":"Int J Epidemiol"},{"key":"R16-13-20210130","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/00002030-200007280-00021","article-title":"Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study","volume":"14","author":"Rezza","year":"2000","journal-title":"AIDS"},{"key":"R17-13-20210130","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00002030-200106150-00012","article-title":"Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain","volume":"15","author":"Gambus","year":"2001","journal-title":"AIDS"},{"key":"R18-13-20210130","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jcv.2005.10.010","article-title":"Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study","volume":"35","author":"Mbulaiteye","year":"2006","journal-title":"J Clin Virol"},{"key":"R19-13-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"R20-13-20210130","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1086\/315503","article-title":"Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma","volume":"181","author":"Jacobson","year":"2000","journal-title":"J Infect Dis"},{"key":"R21-13-20210130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<543::AID-IJC12>3.0.CO;2-7","article-title":"Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV\/HHV-8) seropositivity in a cohort of homosexual men, 1981\u20131996","volume":"77","author":"Melbye","year":"1998","journal-title":"Int J Cancer"},{"key":"R22-13-20210130","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/315039","article-title":"Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma","volume":"180","author":"O'Brien","year":"1999","journal-title":"J Infect Dis"},{"key":"R23-13-20210130","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM199804023381403","article-title":"Sexual transmission and the natural history of human herpesvirus 8 infection","volume":"338","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"R24-13-20210130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.287.2.221","article-title":"Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic","volume":"287","author":"Osmond","year":"2002","journal-title":"JAMA"},{"key":"R25-13-20210130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/oxfordjournals.aje.a010195","article-title":"Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men","volume":"151","author":"Dukers","year":"2000","journal-title":"Am J Epidemiol"},{"key":"R26-13-20210130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/QAI.0b013e31818d5bf8","article-title":"Prevalence and correlates of human herpesvirus 8 infection among Peruvian men who have sex with men","volume":"49","author":"Guanira","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-13-20210130","doi-asserted-by":"crossref","first-page":"e5613","DOI":"10.1371\/journal.pone.0005613","article-title":"High human herpesvirus 8 (HHV-8) prevalence, clinical correlates and high incidence among recently HIV-1-infected subjects in Sao Paulo, Brazil","volume":"4","author":"Batista","year":"2009","journal-title":"PLoS One"},{"key":"R28-13-20210130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm0896-925","article-title":"KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma","volume":"2","author":"Gao","year":"1996","journal-title":"Nat Med"},{"key":"R29-13-20210130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jnci\/90.5.395","article-title":"Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy","volume":"90","author":"Whitby","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R30-13-20210130","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1128\/JCM.40.10.3822-3825.2002","article-title":"Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection","volume":"40","author":"Casper","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R31-13-20210130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/jmv.20627","article-title":"Correlations between synthetic peptide-based enzyme immunoassays and immunofluorescence assay for detection of human herpesvirus 8 antibodies in different Argentine populations","volume":"78","author":"Perez","year":"2006","journal-title":"J Med Virol"},{"key":"R32-13-20210130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.40.02.325-329.2002","article-title":"Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1","volume":"40","author":"Lam","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R33-13-20210130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002030-200301240-00012","article-title":"Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus","volume":"17","author":"Cannon","year":"2003","journal-title":"AIDS"},{"key":"R34-13-20210130","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/sj.bjc.6603100","article-title":"A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein\u2013Barr virus in adults with human immunodeficiency virus-1","volume":"94","author":"Newton","year":"2006","journal-title":"Br J Cancer"},{"key":"R35-13-20210130","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/JCM.01264-06","article-title":"Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis","volume":"45","author":"Nascimento","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R36-13-20210130","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/QAD.0b013e3282fc9c03","article-title":"Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era","volume":"22","author":"Boffi El Amari","year":"2008","journal-title":"AIDS"},{"key":"R37-13-20210130","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/00002030-200308150-00015","article-title":"Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma","volume":"17","author":"Engels","year":"2003","journal-title":"AIDS"},{"key":"R38-13-20210130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcv.2003.09.017","article-title":"Epidemiology of HHV-8 infection in HIV-positive patients with and without Kaposi sarcoma: diagnostic relevance of serology and PCR","volume":"30","author":"Albrecht","year":"2004","journal-title":"J Clin Virol"},{"key":"R39-13-20210130","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/QAD.0b013e3282202b7d","article-title":"Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma","volume":"21","author":"Laney","year":"2007","journal-title":"AIDS"},{"key":"R40-13-20210130","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/00002030-200409030-00011","article-title":"Repeated measures study of human herpesvirus 8 (HHV-8) DNA and antibodies in men seropositive for both HHV-8 and HIV","volume":"18","author":"Laney","year":"2004","journal-title":"AIDS"},{"key":"R41-13-20210130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1386-6532(99)00078-5","article-title":"Detection of human herpesvirus 8 DNA and antibodies to latent nuclear and lytic-phase antigens in serial samples from aids patients with Kaposis sarcoma.","volume":"16","author":"Camera Pierrotti","year":"2000","journal-title":"J Clin Virol"},{"key":"R42-13-20210130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2007.12.025","article-title":"Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions","volume":"263","author":"Nsubuga","year":"2008","journal-title":"Cancer Lett"},{"key":"R43-13-20210130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ijc.10817","article-title":"The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV\/HHV-8) in adults with cancer in Uganda","volume":"103","author":"Newton","year":"2003","journal-title":"Int J Cancer"},{"key":"R44-13-20210130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200304150-00010","article-title":"Immune deficiency and risk for malignancy among persons with AIDS","volume":"32","author":"Mbulaiteye","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R45-13-20210130","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM199906173402403","article-title":"Antibodies against human herpesvirus 8 in black South African patients with cancer","volume":"340","author":"Sitas","year":"1999","journal-title":"N Engl J Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201009100-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:23:18Z","timestamp":1786040598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201009100-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,10]]},"references-count":45,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833b7830","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,10]]}}}